Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.28877
Abstract: Key Points Question Is there equitable geographic access to chimeric antigen receptor–T cells (CAR-T) and bispecific antibodies trials for multiple myeloma in the US? Findings In this cross-sectional study of data from 69 clinical trials… read more here.
Keywords: trials multiple; multiple myeloma; antibodies trials; access chimeric ... See more keywords
Randomization tests in clinical trials with multiple imputation for handling missing data
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Biopharmaceutical Statistics"
DOI: 10.1080/10543406.2022.2080695
Abstract: ABSTRACT Randomization-based inference is a useful alternative to traditional population model-based methods. In trials with missing data, multiple imputation is often used. We describe how to construct a randomization test in clinical trials where multiple… read more here.
Keywords: randomization; clinical trials; missing data; multiple imputation ... See more keywords
Clinical trials in multiple sclerosis: past, present, and future.
Sign Up to like & getrecommendations! Published in 2022 at "Neurologia i neurochirurgia polska"
DOI: 10.5603/pjnns.a2022.0041
Abstract: For the past four decades, multiple sclerosis (MS) has been a focus for clinical trial development and execution. Advances in translational neuroimmunology have led to the development of effective disease-modifying therapies (DMTs) that greatly benefit… read more here.
Keywords: clinical trials; disease; sclerosis past; trials multiple ... See more keywords